<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">kpccz</journal-id><journal-title-group><journal-title xml:lang="ru">Комплексные проблемы сердечно-сосудистых заболеваний</journal-title><trans-title-group xml:lang="en"><trans-title>Complex Issues of Cardiovascular Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2306-1278</issn><issn pub-type="epub">2587-9537</issn><publisher><publisher-name>Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17802/2306-1278-2026-15-2-85-95</article-id><article-id custom-type="elpub" pub-id-type="custom">kpccz-1862</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ. Трансплантология и искусственные органы</subject></subj-group></article-categories><title-group><article-title>ЭФФЕКТИВНОСТЬ ФЛУОРЕСЦЕНТНЫХ АНТИТЕЛ ЧЕЛОВЕКА В ОЦЕНКЕ РЕМОДЕЛИРОВАНИЯ ТКАНЕИНЖЕНЕРНЫХ КОНСТРУКЦИЙ, ПРОШЕДШИХ ПРЕКЛИНИЧЕСКИЕ ИСПЫТАНИЯ НА ЖИВОТНОЙ МОДЕЛИ</article-title><trans-title-group xml:lang="en"><trans-title>EFFECTIVENESS OF HUMAN FLUORESCENT ANTIBODIES IN EVALUATING THE REMODELING OF TISSUE-ENGINEERED CONSTRUCTS HAVING UNDERGONE PRECLINICAL TESTING IN AN ANIMAL MODEL</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-0683-991X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торгунакова</surname><given-names>Евгения Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Torgunakova</surname><given-names>Evgeniya A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>младший научный сотрудник лаборатории клеточных технологий отдела экспериментальной медицины федерального государственного бюджетного научного учреждения «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», Кемерово, Российская Федерация</p></bio><bio xml:lang="en"><p>Junior Researcher, Laboratory of Cell Technologies, Department of Experimental Medicine, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation</p></bio><email xlink:type="simple">evgeniyatorgunakova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9430-937X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сенокосова</surname><given-names>Евгения Андреевна</given-names></name><name name-style="western" xml:lang="en"><surname>Senokosova</surname><given-names>Evgeniya A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат биологических наук заведующая лабораторией клеточных технологий отдела экспериментальной медицины федерального государственного бюджетного научного учреждения «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», Кемерово, Российская Федерация</p></bio><bio xml:lang="en"><p>PhD, Head of the Laboratory of Cell, Department of Experimental Medicine, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation</p></bio><email xlink:type="simple">sergeewa.ew@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2500-2147</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кривкина</surname><given-names>Евгения Олеговна</given-names></name><name name-style="western" xml:lang="en"><surname>Krivkina</surname><given-names>Evgeniya O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>младший научный сотрудник лаборатории клеточных технологий отдела экспериментальной медицины федерального государственного бюджетного научного учреждения «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», Кемерово, Российская Федерация</p></bio><bio xml:lang="en"><p>Junior Researcher, Laboratory of Cell Technologies, Department of Experimental Medicine, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation</p></bio><email xlink:type="simple">kriveo@kemcardio.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8826-9244</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ханова</surname><given-names>Марьям Юрисовна</given-names></name><name name-style="western" xml:lang="en"><surname>Khanova</surname><given-names>Mariam Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат биологических наук научный сотрудник лаборатории клеточных технологий отдела экспериментальной медицины федерального государственного бюджетного научного учреждения «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», Кемерово, Российская Федерация</p></bio><bio xml:lang="en"><p>PhD, Researcher, Laboratory of Cell Technologies, Department of Experimental Medicine, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation</p></bio><email xlink:type="simple">hanomu@kemcardio.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-9323-8893</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коломеец</surname><given-names>Марина Сергеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Kolomeets</surname><given-names>Marina S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>младший научный сотрудник лаборатории клеточных технологий отдела экспериментальной медицины федерального государственного бюджетного научного учреждения «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», Кемерово, Российская Федерация</p></bio><bio xml:lang="en"><p>Junior Researcher, Laboratory of Cell Technologies, Department of Experimental Medicine, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation</p></bio><email xlink:type="simple">koloms@kemcardio.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8846-5077</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миронов</surname><given-names>Андрей Владимирович</given-names></name><name name-style="western" xml:lang="en"><surname>Mironov</surname><given-names>Andrey V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук младший научный сотрудник лаборатории клеточных технологий отдела экспериментальной медицины федерального государственного бюджетного научного учреждения «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», Кемерово, Российская Федерация</p></bio><bio xml:lang="en"><p>PhD, Junior Researcher at the Laboratory of Cellular Technologies, Department of Experimental Medicine, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation</p></bio><email xlink:type="simple">miroav@kemcardio.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8874-0788</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антонова</surname><given-names>Лариса Валерьевна</given-names></name><name name-style="western" xml:lang="en"><surname>Antonova</surname><given-names>Larisa V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук ведущий научный сотрудник лаборатории клеточных технологий отдела экспериментальной медицины федерального государственного бюджетного научного учреждения «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», Кемерово, Российская Федерация</p></bio><bio xml:lang="en"><p>PhD, MD, Leading Researcher, Laboratory of Cell Technologies, Department of Experimental Medicine, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation</p></bio><email xlink:type="simple">antolv@kemcardio.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федеральное государственное бюджетное научное учреждение «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний»<country>Россия</country></aff><aff xml:lang="en">Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>04</day><month>05</month><year>2026</year></pub-date><volume>15</volume><issue>2</issue><fpage>85</fpage><lpage>95</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Торгунакова Е.А., Сенокосова Е.А., Кривкина Е.О., Ханова М.Ю., Коломеец М.С., Миронов А.В., Антонова Л.В., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Торгунакова Е.А., Сенокосова Е.А., Кривкина Е.О., Ханова М.Ю., Коломеец М.С., Миронов А.В., Антонова Л.В.</copyright-holder><copyright-holder xml:lang="en">Torgunakova E.A., Senokosova E.A., Krivkina E.O., Khanova M.Y., Kolomeets M.S., Mironov A.V., Antonova L.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nii-kpssz.com/jour/article/view/1862">https://www.nii-kpssz.com/jour/article/view/1862</self-uri><abstract><sec><title>Основные положения</title><p>Основные положения</p></sec><sec><title> </title><p> </p></sec><sec><title>Цель</title><p>Цель. Разработка панелей иммунофлуоресцентного исследования на основе человек-специфических антител для возможности расширения детекции ремоделирования тканеинженерных конструкций в ходе преклинических испытаний на модели павианов.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Выполнена сравнительная оценка чувствительности иммунофлуоресцентных антител на образцах интактных внутренних грудных артерий человека и образцах эксплантированных тканеинженерных сосудистых протезов (ТСП), имплантированных в бедренные артерии павианов на 6 месяцев. Доказана таргетность человек-специфических антител CD31, vWF, Coll IV, α-SMA и Vimentin в отношении павианов. Разработаны панели флуоресцентной визуализации ремоделирования ТСП. Интенсивность флуоресценции оценивали с помощью сканирующей лазерной микроскопии. Статистическую обработку данных проводили в программе GraphPad Prism 8.</p></sec><sec><title>Результаты</title><p>Результаты. Доказано, что использование человек-специфических антител CD31, vWF, Coll IV, α-SMA и виментин позволило детектировать следующие элементы новообразованной сосудистой ткани, сформированных на основе ТСП спустя 6 месяцев после их имплантации в бедренные артерии павианов: эндотелиальные клетки, внеклеточный матрикс, гладкомышечноподобные и фибробластоподобные клетки.</p></sec><sec><title>Заключение</title><p>Заключение. Разработанные мультиплексные панели иммунофлуоресцентной визуализации отразили основные признаки ремоделирования ТСП у павианов, по многим параметрам схожей с нативной сосудистой стенкой, что подтверждает их эффективность для мониторинга формирования новообразованной сосудистой ткани.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Highlights</title><p>Highlights</p></sec><sec><title> </title><p> </p></sec><sec><title>Aim</title><p>Aim. To develop immunofluorescence assay panels based on human-specific antibodies to enable the detection of tissue-engineered construct remodeling during preclinical trials in baboon models.</p></sec><sec><title>Methods</title><p>Methods. A comparative assessment of the sensitivity of immunofluorescent antibodies was performed using samples of intact human internal mammary artery and explanted tissue-engineered vascular prostheses implanted into the femoral arteries of baboon for six months. The cross-reactivity and targeting capability of human antibodies against CD31, vWF, collagen IV, α-smooth muscle actin, and vimentin were demonstrated in relation to baboon tissues. Immunofluorescence visualization panels for assessing the remodeling of tissue-engineered vascular prostheses were developed. Fluorescence intensity was evaluated using scanning laser microscopy. Fluorescence intensity was assessed using scanning laser microscopy. Statistical data processing was performed using GraphPad Prism 8.</p></sec><sec><title>Results</title><p>Results. It was demonstrated that the use of human antibodies against CD31, vWF, collagen IV, α-smooth muscle actin, and vimentin enabled the detection of key components of newly formed vascular tissue six months after implantation of tissue-engineered vascular prostheses into the femoral arteries of baboons, including endothelial cells, extracellular matrix, smooth muscle–like cells, and fibroblast-like cells.</p></sec><sec><title>Conclusion</title><p>Conclusion. The developed multiplex immunofluorescence imaging panels reflected the main features of tissue-engineered construct remodeling in primates, which is similar to the native vascular wall in many parameters, confirming their effectiveness for monitoring the formation of newly formed vascular tissue.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>Тканеинженерные сосудистые протезы</kwd><kwd>Конфокальная микроскопия</kwd><kwd>Иммунофлуоресценция</kwd><kwd>Тестирование антител</kwd><kwd>Таргетность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Tissue-engineered vascular prostheses</kwd><kwd>Confocal microscopy</kwd><kwd>Immunofluorescence</kwd><kwd>Antibody validation</kwd><kwd>Targeting</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Результаты получены при поддержке Российской Федерации в лице Министерства науки и высшего образования РФ в рамках Соглашения о предоставлении из федерального бюджета грантов в форме субсидий от «30» сентября 2022 г. № 075-15-2022-1202, ком-плексной научно-технической программы полного инновационного цикла «Разработка и внедрение комплекса технологий в областях разведки и добычи твердых полезных иско-паемых, обеспечения промышленной безопасности, биоремедиации, создания новых про-дуктов глубокой переработки из угольного сырья при последовательном снижении эко-логической нагрузки на окружающую среду и рисков для жизни населения» (утвержден-ной распоряжением Правительства Российской Федерации от 11 мая 2022 г. № 1144-р)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Antonova, L. V., Sevostianova, V. V., Silnikov, V. N., Krivkina, E. O., Velikanova, E. A., Mironov, A. V., Shabaev, A. R., Senokosova, E. A., Khanova, M. Y., Glushkova, T. V., Akentieva, T. N., Sinitskaya, A. V., Markova, V. E., Shishkova, D. K., Lobov, A. A., Repkin, E. A., Stepanov, A. D., Kutikhin, A. G., &amp; Barbarash, L. S. (2023). Comparison of the Patency and Regenerative Potential of Biodegradable Vascular Prostheses of Different Polymer Compositions in an Ovine Model. International Journal of Molecular Sciences, 24(10), 8540. doi:10.3390/ijms24108540</mixed-citation><mixed-citation xml:lang="en">Antonova, L. V., Sevostianova, V. V., Silnikov, V. N., Krivkina, E. O., Velikanova, E. A., Mironov, A. V., Shabaev, A. R., Senokosova, E. A., Khanova, M. Y., Glushkova, T. V., Akentieva, T. N., Sinitskaya, A. V., Markova, V. E., Shishkova, D. K., Lobov, A. A., Repkin, E. A., Stepanov, A. D., Kutikhin, A. G., &amp; Barbarash, L. S. (2023). Comparison of the Patency and Regenerative Potential of Biodegradable Vascular Prostheses of Different Polymer Compositions in an Ovine Model. International Journal of Molecular Sciences, 24(10), 8540. doi:10.3390/ijms24108540</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Лапин Б.А., Данилова И.Г. Перспективные направления экспериментального использования обезьян. Вестник Российской академии наук. 2020;90(1):40-46. doi:10.31857/S0869587320010077.</mixed-citation><mixed-citation xml:lang="en">Lapin B.A., Danilova I.G. Perspektivny`e napravleniya e`ksperimental`nogo ispol`zovaniya obez`yan. Vestnik Rossijskoj akademii nauk. 2020;90(1):40-46. doi:10.31857/S0869587320010077.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bergmeister H., Podesser B.K. Preclinical In Vivo Assessment of Tissue Engineered Vascular Grafts and Selection of Appropriate Animal Models. In: Walpoth, B.H., Bergmeister, H., Bowlin, G.L., Kong, D., Rotmans, J.I., Zilla, P. (eds) Tissue-Engineered Vascular Grafts. Reference Series in Biomedical Engineering. 2020; 63-93. Springer, Cham. doi:10.1007/978-3-030-05336-9_5.</mixed-citation><mixed-citation xml:lang="en">Bergmeister H., Podesser B.K. Preclinical In Vivo Assessment of Tissue Engineered Vascular Grafts and Selection of Appropriate Animal Models. In: Walpoth, B.H., Bergmeister, H., Bowlin, G.L., Kong, D., Rotmans, J.I., Zilla, P. (eds) Tissue-Engineered Vascular Grafts. Reference Series in Biomedical Engineering. 2020; 63-93. Springer, Cham. doi:10.1007/978-3-030-05336-9_5.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor, C. B., Cox, G. E., Manalo-estrella, P., Southworth, J., Patton, D. E., &amp; Cathcart, C. (1962). Atherosclerosis in rhesus monkeys. II. Arterial lesions associated with hypercholesteremia induced by dietary fat and cholesterol. Archives of pathology, 74, 16–34.</mixed-citation><mixed-citation xml:lang="en">Taylor, C. B., Cox, G. E., Manalo-estrella, P., Southworth, J., Patton, D. E., &amp; Cathcart, C. (1962). Atherosclerosis in rhesus monkeys. II. Arterial lesions associated with hypercholesteremia induced by dietary fat and cholesterol. Archives of pathology, 74, 16–34.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gresham, G. A., Howard, A. N., Mcqueen, J., &amp; Bowyer, D. E. (1965). Atherosclerosis in primates. British journal of experimental pathology, 46(1), 94–103.</mixed-citation><mixed-citation xml:lang="en">Gresham, G. A., Howard, A. N., Mcqueen, J., &amp; Bowyer, D. E. (1965). Atherosclerosis in primates. British journal of experimental pathology, 46(1), 94–103.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Clarkson, T. B., Lofland, H. B., Bullock, B. C., Lehner, N. D., St Clair, R., &amp; Prichard, R. W. (1969). Atherosclerosis in some species of New World monkeys. Annals of the New York Academy of Sciences, 162(1), 103–109. doi:10.1111/j.1749-6632.1969.tb56354.x</mixed-citation><mixed-citation xml:lang="en">Clarkson, T. B., Lofland, H. B., Bullock, B. C., Lehner, N. D., St Clair, R., &amp; Prichard, R. W. (1969). Atherosclerosis in some species of New World monkeys. Annals of the New York Academy of Sciences, 162(1), 103–109. doi:10.1111/j.1749-6632.1969.tb56354.x</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Didisheim, P., Dewanjee, M. K., Kaye, M. P., Frisk, C. S., Fass, D. N., Wahner, H. W., Tirrell, M. V., &amp; Zollman, P. E. (1984). Nonpredictability of long-term in vivo response from short-term in vitro or ex vivo blood-material interactions. Transactions - American Society for Artificial Internal Organs, 30, 370–376.</mixed-citation><mixed-citation xml:lang="en">Didisheim, P., Dewanjee, M. K., Kaye, M. P., Frisk, C. S., Fass, D. N., Wahner, H. W., Tirrell, M. V., &amp; Zollman, P. E. (1984). Nonpredictability of long-term in vivo response from short-term in vitro or ex vivo blood-material interactions. Transactions - American Society for Artificial Internal Organs, 30, 370–376.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Im, K., Mareninov, S., Diaz, M. F. P., &amp; Yong, W. H. (2019). An Introduction to Performing Immunofluorescence Staining. Methods in molecular biology (Clifton, N.J.), 1897, 299–311. doi:10.1007/978-1-4939-8935-5_26</mixed-citation><mixed-citation xml:lang="en">Im, K., Mareninov, S., Diaz, M. F. P., &amp; Yong, W. H. (2019). An Introduction to Performing Immunofluorescence Staining. Methods in molecular biology (Clifton, N.J.), 1897, 299–311. doi:10.1007/978-1-4939-8935-5_26</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wang, J., Guo, Y., Xu, D., Cui, J., Wang, Y., Su, Y., Liu, Y., Shen, Y., Jing, X., &amp; Bai, W. (2022). The immunolocalization of cluster of differentiation 31, phalloidin and alpha smooth muscle actin on vascular network of normal and ischemic rat brain. Scientific reports, 12(1), 22288. doi:10.1038/s41598-022-26831-6</mixed-citation><mixed-citation xml:lang="en">Wang, J., Guo, Y., Xu, D., Cui, J., Wang, Y., Su, Y., Liu, Y., Shen, Y., Jing, X., &amp; Bai, W. (2022). The immunolocalization of cluster of differentiation 31, phalloidin and alpha smooth muscle actin on vascular network of normal and ischemic rat brain. Scientific reports, 12(1), 22288. doi:10.1038/s41598-022-26831-6</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Saper C. B. (2009). A guide to the perplexed on the specificity of antibodies. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society, 57(1), 1–5. doi:10.1369/jhc.2008.952770</mixed-citation><mixed-citation xml:lang="en">Saper C. B. (2009). A guide to the perplexed on the specificity of antibodies. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society, 57(1), 1–5. doi:10.1369/jhc.2008.952770</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">How to choose and use antibodies | Abcam. https://www.abcam.com/en-us/technical-resources/guides/antibody-basics/how-to-choose-and-use-antibodies (accessed 17.12.2025) (In Engl.)</mixed-citation><mixed-citation xml:lang="en">How to choose and use antibodies | Abcam. https://www.abcam.com/en-us/technical-resources/guides/antibody-basics/how-to-choose-and-use-antibodies (accessed 17.12.2025) (In Engl.)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Smith, L. E., Smallwood, R., &amp; Macneil, S. (2010). A comparison of imaging methodologies for 3D tissue engineering. Microscopy research and technique, 73(12), 1123–1133. doi:10.1002/jemt.20859</mixed-citation><mixed-citation xml:lang="en">Smith, L. E., Smallwood, R., &amp; Macneil, S. (2010). A comparison of imaging methodologies for 3D tissue engineering. Microscopy research and technique, 73(12), 1123–1133. doi:10.1002/jemt.20859</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Elliott A. D. (2020). Confocal Microscopy: Principles and Modern Practices. Current protocols in cytometry, 92(1), e68. doi:10.1002/cpcy.68</mixed-citation><mixed-citation xml:lang="en">Elliott A. D. (2020). Confocal Microscopy: Principles and Modern Practices. Current protocols in cytometry, 92(1), e68. doi:10.1002/cpcy.68</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu, J., &amp; Kaufman, L. J. (2014). Collagen I self-assembly: revealing the developing structures that generate turbidity. Biophysical journal, 106(8), 1822–1831. doi:10.1016/j.bpj.2014.03.011</mixed-citation><mixed-citation xml:lang="en">Zhu, J., &amp; Kaufman, L. J. (2014). Collagen I self-assembly: revealing the developing structures that generate turbidity. Biophysical journal, 106(8), 1822–1831. doi:10.1016/j.bpj.2014.03.011</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bardsley, K., Deegan, A. J., El Haj, A., &amp; Yang, Y. (2017). Current State-of-the-Art 3D Tissue Models and Their Compatibility with Live Cell Imaging. Advances in experimental medicine and biology, 1035, 3–18. doi:10.1007/978-3-319-67358-5_1</mixed-citation><mixed-citation xml:lang="en">Bardsley, K., Deegan, A. J., El Haj, A., &amp; Yang, Y. (2017). Current State-of-the-Art 3D Tissue Models and Their Compatibility with Live Cell Imaging. Advances in experimental medicine and biology, 1035, 3–18. doi:10.1007/978-3-319-67358-5_1</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">López-Chicón, P., Riba-Tietz, T., Fariñas, O., Gelber, P. E., Casaroli-Marano, R. P., &amp; Vilarrodona, A. (2022). A Comparative Study Using Fluorescent Confocal Microscopy and Flow Cytometry to Evaluate Chondrocyte Viability in Human Osteochondral Allografts. Bioengineering (Basel, Switzerland), 9(10), 515. doi:10.3390/bioengineering9100515</mixed-citation><mixed-citation xml:lang="en">López-Chicón, P., Riba-Tietz, T., Fariñas, O., Gelber, P. E., Casaroli-Marano, R. P., &amp; Vilarrodona, A. (2022). A Comparative Study Using Fluorescent Confocal Microscopy and Flow Cytometry to Evaluate Chondrocyte Viability in Human Osteochondral Allografts. Bioengineering (Basel, Switzerland), 9(10), 515. doi:10.3390/bioengineering9100515</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Poole, J. J. A., &amp; Mostaço-Guidolin, L. B. (2021). Optical Microscopy and the Extracellular Matrix Structure: A Review. Cells, 10(7), 1760. doi:10.3390/cells10071760</mixed-citation><mixed-citation xml:lang="en">Poole, J. J. A., &amp; Mostaço-Guidolin, L. B. (2021). Optical Microscopy and the Extracellular Matrix Structure: A Review. Cells, 10(7), 1760. doi:10.3390/cells10071760</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wu, Y., &amp; Wagner, W. D. (2024). Syndecan-4 Functionalization Reduces the Thrombogenicity of Engineered Vascular Biomaterials. Annals of biomedical engineering, 52(7), 1873–1882. doi:10.1007/s10439-023-03199-w</mixed-citation><mixed-citation xml:lang="en">Wu, Y., &amp; Wagner, W. D. (2024). Syndecan-4 Functionalization Reduces the Thrombogenicity of Engineered Vascular Biomaterials. Annals of biomedical engineering, 52(7), 1873–1882. doi:10.1007/s10439-023-03199-w</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Senokosova E.A., Krivkina E.O., Mironov A.V., Sardin E.S., Sergeeva T.Yu., Matveeva V.G., Khanova M.Yu., Torgunakova E.A., Mukhamadiyarov R.A., Antonova L.V. Results of preclinical tests of small-diameter tissue engineered vascular grafts on the primate model. Complex Issues of Cardiovascular Diseases. 2024;13(4):90-103. doi:10.17802/2306-1278-2024-13-4-90-103</mixed-citation><mixed-citation xml:lang="en">Senokosova E.A., Krivkina E.O., Mironov A.V., Sardin E.S., Sergeeva T.Yu., Matveeva V.G., Khanova M.Yu., Torgunakova E.A., Mukhamadiyarov R.A., Antonova L.V. Results of preclinical tests of small-diameter tissue engineered vascular grafts on the primate model. Complex Issues of Cardiovascular Diseases. 2024;13(4):90-103. doi:10.17802/2306-1278-2024-13-4-90-103</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Naito, Y., Williams-Fritze, M., Duncan, D. R., Church, S. N., Hibino, N., Madri, J. A., Humphrey, J. D., Shinoka, T., &amp; Breuer, C. K. (2012). Characterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation. Cells, tissues, organs, 195(1-2), 60–72. doi:10.1159/000331405</mixed-citation><mixed-citation xml:lang="en">Naito, Y., Williams-Fritze, M., Duncan, D. R., Church, S. N., Hibino, N., Madri, J. A., Humphrey, J. D., Shinoka, T., &amp; Breuer, C. K. (2012). Characterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation. Cells, tissues, organs, 195(1-2), 60–72. doi:10.1159/000331405</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Fayon, A., Menu, P., &amp; El Omar, R. (2021). Cellularized small-caliber tissue-engineered vascular grafts: looking for the ultimate gold standard. NPJ Regenerative medicine, 6(1), 46. doi:10.1038/s41536-021-00155-x</mixed-citation><mixed-citation xml:lang="en">Fayon, A., Menu, P., &amp; El Omar, R. (2021). Cellularized small-caliber tissue-engineered vascular grafts: looking for the ultimate gold standard. NPJ Regenerative medicine, 6(1), 46. doi:10.1038/s41536-021-00155-x</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
